128 related articles for article (PubMed ID: 11239552)
1. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a 3-year follow-up evaluation.
Donnez J; Vilos G; Gannon MJ; Maheux R; Emanuel MH; Istre O;
Fertil Steril; 2001 Mar; 75(3):620-2. PubMed ID: 11239552
[TBL] [Abstract][Full Text] [Related]
2. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
Donnez J; Vilos G; Gannon MJ; Stampe-Sorensen S; Klinte I; Miller RM
Fertil Steril; 1997 Jul; 68(1):29-36. PubMed ID: 9207580
[TBL] [Abstract][Full Text] [Related]
3. [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex].
Tiufekchieva E; Nikolov A
Akush Ginekol (Sofiia); 2002; 41(2):30-4. PubMed ID: 12066549
[TBL] [Abstract][Full Text] [Related]
4. Chemical ablation of endometrium with trichloroacetic acid.
Kucukozkan T; Kadioglu BG; Uygur D; Moroy P; Mollamahmutoglu L; Besli M
Int J Gynaecol Obstet; 2004 Jan; 84(1):41-6. PubMed ID: 14698828
[TBL] [Abstract][Full Text] [Related]
5. A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation.
Garry R; Khair A; Mooney P; Stuart M
Br J Obstet Gynaecol; 1996 Apr; 103(4):339-44. PubMed ID: 8605131
[TBL] [Abstract][Full Text] [Related]
6. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
7. Goserelin Acetate as Adjunctive Therapy for Endometrial Ablation in Women with Dysfunctional Uterine Bleeding.
Vilos GA; Donnez J; Gannon M; Stampe-Sorensen S; Klinte J; Miller RM
J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4, Supplement):S54-5. PubMed ID: 9074262
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation.
Shawki O; Peters A; Abraham-Hebert S
JSLS; 2002; 6(1):23-7. PubMed ID: 12002292
[TBL] [Abstract][Full Text] [Related]
10. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Abbott J; Hawe J; Hunter D; Garry R
Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
[TBL] [Abstract][Full Text] [Related]
12. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Aberdeen Endometrial Ablation Trials Group.
Br J Obstet Gynaecol; 1999 Apr; 106(4):360-6. PubMed ID: 10426244
[TBL] [Abstract][Full Text] [Related]
13. Has endometrial ablation replaced hysterectomy for the treatment of dysfunctional uterine bleeding? National figures.
Bridgman SA; Dunn KM
BJOG; 2000 Apr; 107(4):531-4. PubMed ID: 10759274
[TBL] [Abstract][Full Text] [Related]
14. The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding.
Colacurci N; De Placido G; Galasso M; Mollo A; Perino A; Cittadini E
Acta Eur Fertil; 1991; 22(4):229-31. PubMed ID: 1844328
[TBL] [Abstract][Full Text] [Related]
15. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
Benagiano G; Kivinen ST; Fadini R; Cronjé H; Klintorp S; van der Spuy ZM
Fertil Steril; 1996 Aug; 66(2):223-9. PubMed ID: 8690106
[TBL] [Abstract][Full Text] [Related]
16. Endometrial ablation versus hysterectomy: STOP-DUB.
Weber AM; Munro MG
Medscape Womens Health; 1998 May; 3(3):3. PubMed ID: 9732095
[TBL] [Abstract][Full Text] [Related]
17. Endometrial resection and preoperative LH-RH agonists: a prospective 5-year trial.
Zapico A; Grassa A; Martínez E; Menéndez M; Cortés Prieto J
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):114-8. PubMed ID: 15734095
[TBL] [Abstract][Full Text] [Related]
18. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents.
Sculpher M; Thompson E; Brown J; Garry R
BJOG; 2000 Mar; 107(3):340-6. PubMed ID: 10740330
[TBL] [Abstract][Full Text] [Related]
19. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
Franke HR; Snaaijer FF; Houben PW; van der Mooren MJ
Gynecol Endocrinol; 2006 Dec; 22(12):692-7. PubMed ID: 17162712
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
Donnez J; Hervais Vivancos B; Kudela M; Audebert A; Jadoul P
Fertil Steril; 2003 Jun; 79(6):1380-9. PubMed ID: 12798886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
